After My Breast Cancer Diagnosis, My Practice Became a Lab for ChangeAfter My Breast Cancer Diagnosis, My Practice Became a Lab for Change
(MedPage Today) — When I met the patient in my clinic, she was accompanied by her daughter and husband, who both looked completely frustrated with her. I went through my standard spiel about the necessity of radiation after a lumpectomy or a complete…
Brazilian research reveals how some types of breast cancer ‘evade’ treatmentBrazilian research reveals how some types of breast cancer ‘evade’ treatment
Brazilian researchers have identified previously unknown forms of a protein linked to breast cancer. The discovery contributes to our understanding of variability in responses to treatment, even with the most advanced therapies.
Discussing Personalized Treatment Options in Breast CancerDiscussing Personalized Treatment Options in Breast Cancer
(MedPage Today) — In “Beyond Diagnosis: Breast Cancer,” Cleveland Clinic oncologist Tiffany Onger, MD, and host John Mangels continue their conversations on communicating effectively and empathetically with patients across the breast cancer care…
How HER2CLIMB-05 Fits Into First-Line Maintenance Strategies for Breast CancerHow HER2CLIMB-05 Fits Into First-Line Maintenance Strategies for Breast Cancer
(MedPage Today) — At the San Antonio Breast Cancer Symposium, researchers discussed how results from HER2CLIMB-05 may inform first-line maintenance strategies for patients with HER2-positive metastatic breast cancer, alongside data from trials…
GLP-1 Drugs Linked With Chronic CoughGLP-1 Drugs Linked With Chronic Cough
People with type 2 diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists were more likely to develop chronic cough than people using other second-line medications, a new study found. People with type 2 diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists were more likely to develop chronic cough than people using other second-line medications, a new study Read More
Five-Year Absolute Risk–Based and Age-Based Breast Cancer ScreeningFive-Year Absolute Risk–Based and Age-Based Breast Cancer Screening
This decision analytical model study used collaborative simulation modeling to compare the effectiveness and harms associated with mammography screening strategies that vary by 5-year risk of invasive breast cancer vs age-based strategies.
Bariatric surgery beats GLP-1s for type 2 diabetes across income levels, study saysBariatric surgery beats GLP-1s for type 2 diabetes across income levels, study says
When endocrinologist Mary Elizabeth Patti looks at a patient with type 2 diabetes who could benefit from weight loss, she sees more than body mass index and blood glucose levels. She also recognizes the challenges of social vulnerability, understanding how low income, food insecurity, and limited access to health care might matter in treatment choice. Read More
Food Companies Are Targeting Users of Weight-Loss Drugs With ‘GLP-1 Friendly’ LabelsFood Companies Are Targeting Users of Weight-Loss Drugs With ‘GLP-1 Friendly’ Labels
(MedPage Today) — Meals and snacks with “GLP-1 Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity drugs like semaglutide (Wegovy) and tirzepatide (Zepbound) to lose weight… (MedPage Today) — Meals and snacks with “GLP-1 Friendly” labels on the packaging are becoming more Read More
Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menusSmaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus
TK TK
Simple blood test can predict which breast cancer treatment will work best, study findsSimple blood test can predict which breast cancer treatment will work best, study finds
Exclusive: DNA test would mean patients could be offered most effective treatment first, boosting their chances of beating the diseaseScientists have developed a simple DNA blood test that can predict how well patients with breast cancer will respond to treatment.More than 2 million people globally are diagnosed each year with the disease, which is the world’s most prevalent cancer. Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients. Continue reading…